Similar articles

• Fc gamma receptor polymorphisms as predictive markers of Cetuximab efficacy in epidermal growth factor receptor downstream-mutated metastatic colorectal cancer.

  Rodríguez J, Zarate R, Bandres E, Boni V, Hernández A, Sola JJ, Honorato B, Bitarte N, García-Foncillas J. Rodríguez J, et al. Eur J Cancer. 2012 Aug;48(12):1774-80. doi: 10.1016/j.ejca.2012.01.007. Epub 2012 Feb 2. Eur J Cancer. 2012. PMID: 22305465
• Therapeutic targeting of epidermal growth factor receptor with monoclonal antibodies.

  Siena S, Artale S, Vanzulli A, Marrapese G, Bevilacqua L, Secondino S, Sironi O, Schiavo R, Moroni M, Pedrazzoli P. Siena S, et al. Suppl Tumori. 2002 Jul-Aug;1(4):S46-8. Suppl Tumori. 2002. PMID: 12415818 Review. No abstract available.
• Effective inhibition of the epidermal growth factor/epidermal growth factor receptor binding by anti-epidermal growth factor antibodies is related to better survival in advanced non-small-cell lung cancer patients treated with the epidermal growth factor cancer vaccine.

  García B, Neninger E, de la Torre A, Leonard I, Martínez R, Viada C, González G, Mazorra Z, Lage A, Crombet T. García B, et al. Clin Cancer Res. 2008 Feb 1;14(3):840-6. doi: 10.1158/1078-0432.CCR-07-1050. Clin Cancer Res. 2008. PMID: 18245547 Clinical Trial.
• [Trastuzumab and Fcgamma].

  Yamashiro H, Toi M. Yamashiro H, et al. Gan To Kagaku Ryoho. 2008 Jul;35(7):1097-100. Gan To Kagaku Ryoho. 2008. PMID: 18633249 Japanese.
• Genetic polymorphisms of the epidermal growth factor and related receptor in non-small cell lung cancer--a review of the literature.

  Araújo A, Ribeiro R, Azevedo I, Coelho A, Soares M, Sousa B, Pinto D, Lopes C, Medeiros R, Scagliotti GV. Araújo A, et al. Oncologist. 2007 Feb;12(2):201-10. doi: 10.1634/theoncologist.12-2-201. Oncologist. 2007. PMID: 17296816 Review.